Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC 5-(1-methyl-1H-pyrazol-4-yl)-N-(2-methyl-5-(3-(trifluoromethyl)benzamido)phenyl)nicotinamide | 2095849-04-8 | MFCD31813597 | 98.0% | 479.45 g·mol⁻¹ | C25H20F3N5O2 | 5 MG
SDP

Catalog No. 5000245604
Encompass_Preferred

CSF1R-IN-1 is a potent small-molecule inhibitor of the colony-stimulating factor 1 receptor (CSF1R) with a reported IC50 of 0.5 nM. The compound demonstrates good intestinal permeability in Caco-2 assays and favorable oral pharmacokinetics in mice, supporting its use for in vivo pharmacology testing in preclinical tumor models.

  • Potent CSF1R inhibition (IC50 = 0.5 nM).
  • Good intestinal permeability in Caco-2 assays.
  • Favorable oral pharmacokinetics in mice for in vivo studies.
  • High purity suitable for research applications.
  • Recommended storage as a powder at -20°C to maintain stability.

Catalog No. 50-002-45604 Supplier Medchemexpress LLC Supplier No. HY1017745MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

CSF1R-IN-1 is a potent small-molecule inhibitor of the colony-stimulating factor 1 receptor (CSF1R) with a reported IC50 of 0.5 nM. The compound demonstrates good intestinal permeability in Caco-2 assays and favorable oral pharmacokinetics in mice, supporting its use for in vivo pharmacology testing in preclinical tumor models.

  • Potent CSF1R inhibition (IC50 = 0.5 nM).
  • Good intestinal permeability in Caco-2 assays.
  • Favorable oral pharmacokinetics in mice for in vivo studies.
  • High purity suitable for research applications.
  • Recommended storage as a powder at -20°C to maintain stability.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.